Status:
COMPLETED
Invasive Candidiasis in Saudi ICUs
Lead Sponsor:
Hasan Al-Dorzi
Collaborating Sponsors:
King Fahad Medical City
Conditions:
Invasive Candidiasis
Eligibility:
All Genders
18+ years
Brief Summary
Epidemiology and clinical outcomes of invasive candidiasis in critically ill patients in Saudi Arabia is not well studied. This observational study objectives include to determine the epidemiology, ri...
Eligibility Criteria
Inclusion
- adult patients (\> 18 years)
- develop invasive candidiasis as per prespecified definitions during ICU stay
- In addition, patients who had invasive candidiasis within 72 hours of ICU admission will be included
Exclusion
- Diagnosis of invasive candidiasis (definite or probable) more than 72 hours before ICU admission.
- Diagnosis of invasive candidiasis (definite or probable) within 72 hours of ICU admission, but the admission to ICU for an unrelated reason.
- Readmission to the ICU during the same hospitalization with invasive candidiasis occurring during one of the previous admissions.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT01490684
Start Date
August 1 2012
End Date
May 1 2016
Last Update
August 24 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
King Abdulaziz Medical City
Riyadh, Saudi Arabia
2
King Fahad Medical City
Riyadh, Saudi Arabia